Individual circumstances determine the optimal choice
Ozempic face, a common side effect of GLP-1 medications, occurs when rapid weight loss leads to diminished fat pads and collagen in the face
Assessment report for GLP-1 based therapies (Article 53 procedure)
hello, lovely friends I reported on access issues around employer insurance last year, sharing interviews with Kristi Turner, who lost her coverage on New Year's Eve while everyone else was celebrating, and Jennifer Sansabrino, a small business owner who genuinely wanted to cover her employees but did not have a single formulary available to her with GLP-1s for weight loss
Based on the Chinese Lipid Management Guidelines 2023, 12 patients who are diagnosed with T2DM and are aged 40 years or older can be considered a high-risk group for ASCVD
The $50 co-pay is expected to cover medications in pill form and injectables that are FDA approved for the treatment of weight loss